bromocriptine has been researched along with Cell Transformation, Neoplastic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juneja, HS; Mhatre, MC; Shah, PN | 1 |
| Burkert, W; Rainov, NG | 1 |
| Downs, TR; Eberhardt, NL; Ebersold, MJ; Frohman, LA; Horvath, E; Kovacs, K; Scheithauer, BW; Whitaker, MD; Young, WF; Zimmerman, D | 1 |
| Lee, WH | 1 |
| Furui, A; Nagasaka, T; Nakashima, N; Wakabayashi, T; Yoshida, J | 1 |
| Gullino, PM | 1 |
| El'tsina, NV | 1 |
1 review(s) available for bromocriptine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
[Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man].
Topics: Animals; Benz(a)Anthracenes; Breast; Breast Neoplasms; Bromocriptine; Cell Differentiation; Cell Transformation, Neoplastic; Female; Humans; Levodopa; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Prolactin | 1976 |
6 other study(ies) available for bromocriptine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Cell Transformation, Neoplastic; Darkness; DNA; Estradiol; Female; Light; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Melatonin; Neoplasms, Radiation-Induced; Pregnancy; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Malignant growth of a recurrent macroprolactinoma after radiation therapy.
Topics: Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lisuride; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1993 |
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Topics: Adenoma; Bromocriptine; Cell Transformation, Neoplastic; Child; Gigantism; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1993 |
Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.
Topics: Animals; Animals, Newborn; Base Sequence; Bromocriptine; Cell Division; Cell Transformation, Neoplastic; Dopamine; Dopamine Agonists; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Retinoblastoma; Heterozygote; Mice; Mice, Mutant Strains; Molecular Sequence Data; Pituitary Gland; Pituitary Neoplasms; Receptors, Dopamine; Tumor Cells, Cultured | 1996 |
Sarcomatous transformation of pituitary adenoma after bromocriptine therapy.
Topics: Adenoma; Adult; Antibodies, Neoplasm; Antigens, Neoplasm; Biomarkers, Tumor; Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Pituitary Neoplasms; Sarcoma | 1998 |
Considerations on the preneoplastic lesions of the mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane | 1977 |